Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivarmacitinib in Refractory Behçet's Disease
NCT07634848Phase 2Withdrawn
- Start
- Jun 2026
- Primary completion
- May 2027
- Countries
- 1
01
Overview
A Phase 2 trial of ivarmacitinib in Behçet's disease (BD). Planned start Jun 2026; status: withdrawn.
02
Drugs
ivarmacitinib
03
Conditions
Behçet's disease (BD)
Beyond the preview
Go deeper on NCT07634848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07634848.